Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
Under healthy conditions, the cornea is an avascular structure which allows for transparency and optimal visual acuity. Its avascular nature is maintained by a balance of proangiogenic and antiangiogenic factors. An imbalance of these factors can result in abnormal blood vessel proliferation into th...
Main Authors: | Zachary Barry, Bomina Park, Timothy W. Corson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/15/3468 |
Similar Items
-
Therapeutic approaches for corneal neovascularization
by: Sepehr Feizi, et al.
Published: (2017-12-01) -
Research expression of Slit3 and Robo4 in corneal neovascularization of rats
by: Shi-Yi Xiao, et al.
Published: (2014-07-01) -
Research progress of cells and molecules in corneal neovascularization
by: Yue-Lan Gao, et al.
Published: (2021-11-01) -
A case of vascularized corneal opacity treated with aflibercept
by: A.S. Cholak, et al.
Published: (2020-02-01) -
Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01)